Argenx Se (ARGX) Non Operating Income (2017 - 2021)
Argenx Se's (ARGX) quarterly Non Operating Income came in at -$325000.0 in Q2 2021, down 127.36% YoY from $1.2 million in Q2 2020, and up 22.62% on a QoQ basis from -$420000.0 in Q1 2021.
Argenx Se (ARGX) Non Operating Income (2017 - 2021) Analysis & Trends
Argenx Se (ARGX) has 5 years of Non Operating Income data on file, last reported at -$325000.0 in Q2 2021.
- Quarterly Non Operating Income fell 127.36% year-over-year to -$325000.0 in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $153924.2 (down 97.17% YoY) and the FY2021 annual result came in at -$944000.0, up 37.11% from the prior year.
- Non Operating Income climbed to -$325000.0 in Q2 2021, from -$420000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $4.0 million in Q3 2019 to a low of -$3.6 million in Q1 2020.
- A 5-year average of $617972.3 and a median of $449462.1 in 2020 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2018 — Non Operating Income surged 18588.22% — and 2021, when it plunged 127.36%.
- Tracing ARGX's Non Operating Income over 5 years: stood at -$3196.2 in 2017, then surged by 18588.22% to $590924.3 in 2018, then soared by 552.98% to $3.9 million in 2019, then plunged by 91.69% to $320726.0 in 2020, then plunged by 201.33% to -$325000.0 in 2021.
- The last three Non Operating Income figures came in at -$325000.0 (Q2 2021), -$420000.0 (Q1 2021), and $320726.0 (Q4 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -139.24 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 12.40 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -51.63 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -53.64 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -325,000.00 |
| Mar 31, 2021 | -420,000.00 |
| Dec 31, 2020 | 320,725.97 |
| Sep 30, 2020 | 578,198.23 |
| Jun 30, 2020 | 1.19 Mn |
| Mar 31, 2020 | -3.59 Mn |
| Dec 31, 2019 | 3.86 Mn |
| Sep 30, 2019 | 3.98 Mn |
| Mar 31, 2018 | 590,924.27 |
| Mar 31, 2017 | -3,196.22 |